SG Americas Securities
RVLP

SG Americas Securities’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

SG Americas Securities’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-13,019
Closed -$49K – 3291
2019
Q2 		$49K Buy
13,019
+628
+5% +$2.09K ﹤0.01% 2917
2019
Q1 		$45K Buy
+12,391
New +$91.2K ﹤0.01% 3211

Other funds holding RVLP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

SG Americas Securities's RVLP Position: Q3 2019 in Review

SG Americas Securities sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2019, closing a stake of 13,019 shares — an estimated $49K sold.

SG Americas Securities first reported a position in RVLP in Q1 2019 and held it in 2 quarters. The position peaked at $49K in Q2 2019. 40 funds tracked by Wall St. Rank hold RVLP as of Q3 2019.

  • SG Americas Securities reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2019 after selling out during the quarter.
  • SG Americas Securities sold 13,019 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2019, an estimated $49K.
  • SG Americas Securities first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2019 and held it in 2 quarters.
  • SG Americas Securities's RVL Pharmaceuticals plc Ordinary Shares position peaked at $49K in Q2 2019.
  • 40 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2019.

Based on SG Americas Securities's 13F filing for Q3 2019, filed 4 Nov 2019.